NEW YORK, June 27 (Praxis Press) Heparins have been shown to be effective and safe in the treatment of deep vein thrombosis, but the use of this treatment on an outpatient versus an inpatient basis ...

Treatment for thrombophlebitis depends on the severity and location of the condition. Options for thrombophlebitis that affect the deep veins may include surgery and medications that help prevent or ...

Myeloproliferative neoplasms (MPNs) are a leading cause of splanchnic vein thrombosis (SVT). SVT is observed in all MPNs and frequently affects young patients. Therapy should be addressed to three ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from entering the body. However, there’s a dark side to blood clotting. A blood clot, ...

An international clinical trial led by Dr. Lana Castellucci of The Ottawa Hospital and the University of Ottawa shows that apixaban is safer than rivaroxaban for treating venous thrombosis. The first ...

Within the next month from the moment of thrombosis, there is a 6% risk that the blood clot will break off, enter the ...

Recently non-Vitamin K antagonist oral anticoagulants (NOAC) is replacing warfarin for the treatment of deep vein thrombosis (DVT). However, the role of NOAC after thrombolysis of acute iliofeomral ...

Lonza has signed a partnership agreement with Anthos Therapeutics, the Swiss company said on Thursday, to develop and manufacture an antibody treatment for blood clots. ZURICH, June 11 (Reuters) - ...

A stent thrombosis is a blood clot that forms within a coronary stent. It can be a complication of stent placement to open a narrowed artery. A coronary stent is a mesh tube that opens a narrowed or ...

Please provide your email address to receive an email when new articles are posted on . Atorvastatin therapy did not reduce risk for venous or arterial thrombosis or all-cause death among patients ...

A rare syndrome has been observed in people following vaccination against COVID-19. This involves thrombosis at unusual sites in the body, associated with a low thrombocyte count and a clotting ...